Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Sell
36
REAL Quote, Financials, Valuation and Earnings
Last price:
$6.22
Seasonality move
:
5.32%
Day range:
$5.92 - $6.35
52-week range:
$2.24 - $11.38
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.14x
P/B ratio:
--
Volume:
3.9M
Avg. volume:
3.8M
1-year change:
70.68%
Market cap:
$693.1M
Revenue:
$600.5M
EPS (TTM):
-$1.29
Analysts' Opinion
-
Consensus RatingThe RealReal has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 3 Buy ratings, 3 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $10.80, The RealReal has an estimated upside of 50.88% from its current price of $6.23.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $8.50 representing 100% downside risk from its current price of $6.23.
Fair Value
-
According to the consensus of 7 analysts, The RealReal has 50.88% upside to fair value with a price target of $10.80 per share.
REAL vs. S&P 500
-
Over the past 5 trading days, The RealReal has overperformed the S&P 500 by 10.49% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
The RealReal does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
The RealReal has grown year-over-year revenues for 4 quarters straight. In the most recent quarter The RealReal reported revenues of $164M.
Earnings Growth
-
The RealReal has grown year-over-year earnings for 0 quarters straight. In the most recent quarter The RealReal reported earnings per share of -$0.62.
Enterprise value:
958.8M
EV / Invested capital:
31.38x
Price / LTM sales:
1.14x
EV / EBIT:
--
EV / Revenue:
1.60x
PEG ratio (5yr expected):
--
EV / Free cash flow:
1,201.48x
Price / Operating cash flow:
857.07x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$447.5M
Return On Assets:
-31.72%
Net Income Margin (TTM):
-22.35%
Return On Equity:
--
Return On Invested Capital:
-141.57%
Operating Margin:
-3.14%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $603.5M | $549.3M | $600.5M | $143.4M | $164M | |
| Gross Profit | $348.7M | $376.3M | $447.5M | $106M | $122.1M | |
| Operating Income | -$188.3M | -$122.8M | -$56.3M | -$15M | -$5.2M | |
| EBITDA | -$158.1M | -$125.8M | -$79.4M | -$10.8M | -$54.1M | |
| Diluted EPS | -$2.05 | -$1.66 | -$1.29 | -$0.20 | -$0.62 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $421.5M | $517.8M | $372.3M | $235.9M | $232.7M | |
| Total Assets | $605.1M | $754.9M | $615.6M | $446.9M | $423.1M | |
| Current Liabilities | $148.3M | $188M | $207.5M | $188.9M | $248.7M | |
| Total Liabilities | $413.8M | $681.8M | $785.7M | $750.2M | $830.5M | |
| Total Equity | $191.3M | $73.1M | -$170.1M | -$303.3M | -$407.4M | |
| Total Debt | $149.2M | $348.4M | $449.8M | $452.4M | $437.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$91.6M | -$61.3M | $26.8M | $10.5M | $28M | |
| Cash From Investing | -$36.9M | -$42.1M | -$25.6M | -$6.7M | -$8.8M | |
| Cash From Financing | $4.1M | $226K | -$4.8M | $262K | -$132K | |
| Free Cash Flow | -$128.5M | -$103.4M | $798K | $3.8M | $19.2M | |
REAL
Sector
Market Cap
$693.1M
$414.9M
Price % of 52-Week High
54.77%
69.93%
Dividend Yield
0%
0%
Shareholder Yield
--
3.88%
1-Year Price Total Return
70.69%
-15.73%
Beta (5-Year)
3.001
0.943
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$5.91
200-day SMA
Buy
Level
$5.05
Bollinger Bands (100)
Sell
Level
4.62 - 9.32
Chaikin Money Flow
Sell
Level
-65.1M
20-day SMA
Buy
Level
$6.12
Relative Strength Index (RSI14)
Sell
Level
46.57
ADX Line
Sell
Level
35.97
Williams %R
Sell
Level
-7.9695
50-day SMA
Sell
Level
$7.76
MACD (12, 26)
Sell
Level
-0.50
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
70.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2.7743)
Sell
CA Score
(Annual)
Level (-7.135)
Buy
Beneish M-Score
(Annual)
Level (-4.4701)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (11.058)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.
Stock Forecast FAQ
In the current month, REAL has received 3 Buy ratings 3 Hold ratings, and 1 Sell ratings. The REAL average analyst price target in the past 3 months is $10.80.
-
Where Will The RealReal Stock Be In 1 Year?
According to analysts, the consensus estimate is that The RealReal share price will rise to $10.80 per share over the next 12 months.
-
What Do Analysts Say About The RealReal?
Analysts are divided on their view about The RealReal share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The RealReal is a Sell and believe this share price will drop from its current level to $8.50.
-
What Is The RealReal's Price Target?
The price target for The RealReal over the next 1-year time period is forecast to be $10.80 according to 7 Wall Street analysts, 3 of them rate the stock a Buy, 1 rates the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is REAL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for The RealReal is a Leans Bullish. 3 of 7 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of REAL?
You can purchase shares of The RealReal via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The RealReal shares.
-
What Is The The RealReal Share Price Today?
The RealReal was last trading at $6.22 per share. This represents the most recent stock quote for The RealReal. Yesterday, The RealReal closed at $6.23 per share.
-
How To Buy The RealReal Stock Online?
In order to purchase The RealReal stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
